These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Comparison of biochemical parameters of benzamide riboside, a new inhibitor of IMP dehydrogenase, with tiazofurin and selenazofurin. Gharehbaghi K, Sreenath A, Hao Z, Paull KD, Szekeres T, Cooney DA, Krohn K, Jayaram HN. Biochem Pharmacol; 1994 Oct 07; 48(7):1413-9. PubMed ID: 7945441 [Abstract] [Full Text] [Related]
7. Synthesis and antitumor activity of 2-beta-D-ribofuranosyloxazole-4-carboxamide (oxazofurin). Franchetti P, Cristalli G, Grifantini M, Cappellacci L, Vittori S, Nocentini G. J Med Chem; 1990 Oct 07; 33(10):2849-52. PubMed ID: 2120442 [Abstract] [Full Text] [Related]
8. Studies on the mechanism of action of tiazofurin metabolism to an analog of NAD with potent IMP dehydrogenase-inhibitory activity. Cooney DA, Jayaram HN, Glazer RI, Kelley JA, Marquez VE, Gebeyehu G, Van Cott AC, Zwelling LA, Johns DG. Adv Enzyme Regul; 1983 Oct 07; 21():271-303. PubMed ID: 6152729 [Abstract] [Full Text] [Related]
9. Nucleoside and non-nucleoside IMP dehydrogenase inhibitors as antitumor and antiviral agents. Franchetti P, Grifantini M. Curr Med Chem; 1999 Jul 07; 6(7):599-614. PubMed ID: 10390603 [Abstract] [Full Text] [Related]
10. Modulation of IMP dehydrogenase activity and guanylate metabolism by tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide). Lui MS, Faderan MA, Liepnieks JJ, Natsumeda Y, Olah E, Jayaram HN, Weber G. J Biol Chem; 1984 Apr 25; 259(8):5078-82. PubMed ID: 6143752 [Abstract] [Full Text] [Related]
13. Cytotoxicity of a new IMP dehydrogenase inhibitor, benzamide riboside, to human myelogenous leukemia K562 cells. Jayaram HN, Gharehbaghi K, Jayaram NH, Rieser J, Krohn K, Paull KD. Biochem Biophys Res Commun; 1992 Aug 14; 186(3):1600-6. PubMed ID: 1354960 [Abstract] [Full Text] [Related]
14. Targets and markers of selective action of tiazofurin. Weber G, Natsumeda Y, Pillwein K. Adv Enzyme Regul; 1985 Aug 14; 24():45-65. PubMed ID: 2424286 [Abstract] [Full Text] [Related]
15. Effects of tiazofurin on protooncogene expression during HL-60 cell differentiation. Kharbanda SM, Sherman ML, Spriggs DR, Kufe DW. Cancer Res; 1988 Nov 01; 48(21):5965-8. PubMed ID: 2901907 [Abstract] [Full Text] [Related]
16. A new C-nucleoside analogue of tiazofurin: synthesis and biological evaluation of 2-beta-D-ribofuranosylimidazole-4-carboxamide (imidazofurin). Franchetti P, Marchetti S, Cappellacci L, Yalowitz JA, Jayaram HN, Goldstein BM, Grifantini M. Bioorg Med Chem Lett; 2001 Jan 08; 11(1):67-9. PubMed ID: 11140736 [Abstract] [Full Text] [Related]
17. The chemistry of nicotinamide adenine dinucleotide (NAD) analogues containing C-nucleosides related to nicotinamide riboside. Pankiewicz KW, Watanabe KA, Lesiak-Watanabe K, Goldstein BM, Jayaram HN. Curr Med Chem; 2002 Apr 08; 9(7):733-41. PubMed ID: 11966436 [Abstract] [Full Text] [Related]
18. Consequences of IMP dehydrogenase inhibition, and its relationship to cancer and apoptosis. Jayaram HN, Cooney DA, Grusch M, Krupitza G. Curr Med Chem; 1999 Jul 08; 6(7):561-74. PubMed ID: 10390601 [Abstract] [Full Text] [Related]
20. IMP dehydrogenase and action of antimetabolites in human cultured blast cells. Yamada Y, Goto H, Yoshino M, Ogasawara N. Biochim Biophys Acta; 1990 Mar 09; 1051(3):209-14. PubMed ID: 1968764 [Abstract] [Full Text] [Related] Page: [Next] [New Search]